Status:
UNKNOWN
French Observational Study of Complications Associated With Anticoagulants and Antiplatelet Treatment in Retina/Vitreous Surgery
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Patients Undergoing Retina/Vitreous Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Anticoagulants and antiplatelet treatments are frequently prescribed treatments to prevent or treat thromboembolic complications and reduce morbidity and mortality related to cardiovascular risk facto...
Eligibility Criteria
Inclusion
- person who has expressed willingness to participate
- person over 18 years of age
- person with a retinal-vitreous condition requiring scheduled surgery (epi-retinal membrane surgery, vitreous traction surgery, macular hole surgery).
Exclusion
- person subject to legal protection (curatorship, guardianship)
- person deemed mentally incompetent
- pregnant, parturient or breastfeeding woman
- adult unwilling or unable to consent
- patient who has already participated in the study
- person with a physical or mental disability that does not allow participation.
- a person who has participated in any study of an experimental medical product within the previous 3 months
- person who experiences any of the following during the ophthalmological examination:
- severe or proliferating diabetic retinopathy
- intra-vitreal hemorrhage
- tractional retinal detachment
- subretinal or retrohyaloidal hematoma.
Key Trial Info
Start Date :
January 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT03863548
Start Date
January 8 2019
End Date
December 1 2019
Last Update
March 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU dijon Bourgogne
Dijon, France, 21000